KE-99 Study

Posted on April 10th, 2014 by ProbioHealth under Studies

Probiotic spectrum of strain KE-99 includes high-affinity intestinal attachment, extended gut retention, attachment-inhibition (prophylactic) / detachment (therapeutic) of several intestinal pathogens, and prominent reduction of ammonia and sulphides in feces. Ongoing dietary supplement trials indicated that KE-99 formulations are highly effective in the clinical management of various intestinal diseases including antibiotic-induced diarrhea, inflammatory bowel disease, irritable bowel syndrome, constipation and influenza-associated diarrhea. A patented oil-based prebiotic anaerobic encapsulation system for an extended preservation of probiotic at room temperature and a rapid recovery after in vivo administration has been developed for a dose-efficient functional delivery of KE-99.

To download the study: KE99 Study

Leave a Reply